Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
Recruiting · NCT06039085 · Observational (researchers observe without assigning treatment) · Lead sponsor: Ryan J. Halter
View the official record on ClinicalTrials.gov →Interventions studied
custom device to demonstrate a significant difference in electrical impedance signatures
What this trial is about
This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Clinical diagnosis of prostate cancer requiring RARP.
- Ability to understand and the willingness to sign a written informed consent document.
- Age ≥ 18 years old
Exclusion criteria
- Adults with implanted electrical devices such as pacemakers
- Prisoners
- Adults with impaired decision-making capacity
- Any condition for which, in the opinion of the investigator, contraindicates study participation.
Where it is running
1 location listed across 1 US state.
- Dartmouth-Hitchcock Medical Center - Lebanon, New Hampshire, United States